Cargando…
Possible involvement of normalized Pin1 expression level and AMPK activation in the molecular mechanisms underlying renal protective effects of SGLT2 inhibitors in mice
BACKGROUND: Recently, clinical studies have shown the protective effects of sodium glucose co-transporter2 (SGLT2) inhibitors against progression of diabetic nephropathy, but the underlying molecular mechanisms remain unclear. METHODS: Diabetic mice were prepared by injecting nicotinamide and strept...
Autores principales: | Inoue, Masa-Ki, Matsunaga, Yasuka, Nakatsu, Yusuke, Yamamotoya, Takeshi, Ueda, Koji, Kushiyama, Akifumi, Sakoda, Hideyuki, Fujishiro, Midori, Ono, Hiraku, Iwashita, Misaki, Sano, Tomomi, Nishimura, Fusanori, Morii, Kenichi, Sasaki, Kensuke, Masaki, Takao, Asano, Tomoichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647324/ https://www.ncbi.nlm.nih.gov/pubmed/31367234 http://dx.doi.org/10.1186/s13098-019-0454-6 |
Ejemplares similares
-
Pin1 Plays Essential Roles in NASH Development by Modulating Multiple Target Proteins
por: Inoue, Masa-Ki, et al.
Publicado: (2019) -
Physiological and Pathogenic Roles of Prolyl Isomerase Pin1 in Metabolic Regulations via Multiple Signal Transduction Pathway Modulations
por: Nakatsu, Yusuke, et al.
Publicado: (2016) -
Pathological Role of Pin1 in the Development of DSS-Induced Colitis
por: Matsunaga, Yasuka, et al.
Publicado: (2021) -
Hepatic Pin1 Expression, Particularly in Nuclei, Is Increased in NASH Patients in Accordance with Evidence of the Role of Pin1 in Lipid Accumulation Shown in Hepatoma Cell Lines
por: Kanna, Machi, et al.
Publicado: (2023) -
Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus
por: Qiang, Shirong, et al.
Publicado: (2015)